COVID-19 and the Importance of Combating Antimicrobial Resistance
In addition to the current global COVID-19 pandemic is the long-term public health crisis of growing Antimicrobial Resistance (AMR) that persists today. Drug-resistant bacteria and fungi are evolving at a rapid pace with fewer and fewer treatment options. Working to Fight AMR seeks to combat this public health crisis by promoting the production of new antimicrobial medicines. According to the organization, scientists have developed only one truly novel antibiotic since 1984, and just 1% of medicines in development globally address bacterial infections.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.